原生T1 mapping与超声弹性成像在肝纤维化分期和监测中的比较:一项关于可重复性、再现性和准确性的动物研究
该动物研究在CCl4诱导的大鼠肝纤维化模型中比较了原生T1 mapping与声辐射力脉冲弹性成像(ARFI)评估肝纤维化的可重复性、再现性及分期监测性能。结果显示两者可重复性相似,分期准确性无显著差异,但原生T1 mapping检测纤维化逆转的准确性(AUC=0.99)显著优于ARFI(AUC=0.56;p=0.002)。
要点
- 原生T1 mapping与ARFI弹性成像在肝纤维化分期上准确性相似,无显著差异。
- 原生T1 mapping检测纤维化逆转的AUC为0.99,显著优于ARFI的0.56。
- 原生T1 mapping可在几乎所有临床MRI设备上测量,无需额外硬件或钆螯合物注射。
核心结论
- 原生T1 mapping可能是无创评估肝纤维化的可靠且准确的方法;与ARFI弹性成像相比,其可重复性和再现性相似,分期准确性相似,检测纤维化逆转的准确性更好。
研究设计与样本
- 动物研究:8只雄性Sprague-Dawley大鼠用于探索可重复性和再现性(ICC);52只大鼠经四氯化碳(CCl4)损伤诱导不同纤维化程度;另16只大鼠构建纤维化进展和逆转模型;采用原生T1 mapping和ARFI弹性成像分别定量原生T1值和剪切波速度(SWV);以METAVIR系统(F0-F4)进行纤维化分期;通过受试者工作特征曲线下面积(AUC)评估定量参数分期和监测纤维化的性能。
诊断标准与关键数值
- 原生T1值诊断显著纤维化(≥F2)的AUC为0.84,诊断肝硬化(F4)的AUC为0.84,检测纤维化进展的AUC为0.75;SWV对应AUC分别为0.81、0.86和0.7;两者性能无显著差异(p≥0.496);检测纤维化逆转时,原生T1值AUC为0.99,优于SWV的AUC=0.56(p=0.002)。
临床应用与阅片要点
- 原生T1 mapping可在几乎所有临床MRI设备上测量,无需额外硬件或钆螯合物注射;与ARFI弹性成像相比,其可重复性和再现性相似,分期准确性相似,检测纤维化逆转的准确性更好。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the repeatability, reproducibility, and staging and monitoring of the performance of native T1 mapping for noninvasively assessing liver fibrosis in comparison with acoustic radiation force impulse (ARFI) elastography.
METHODS: The repeatability and reproducibility were explored in 8 male Sprague-Dawley rats with intraclass correlation coefficient (ICC). Different degrees of fibrosis were induced in 52 rats by carbon-tetrachloride (CCl4) insult. Another 16 rats were used to build fibrosis progression and regression models. The native T1 values and shear wave velocity (SWV) were quantified by using native T1 mapping and ARFI elastography, respectively. The METAVIR system (F0-F4) was used for the staging of fibrosis. The area under the receiver operating characteristic curve (AUC) was determined to assess the performance of quantitative parameters for staging and monitoring fibrosis.
RESULTS: Native T1 values shared similar good repeatability (ICC = 0.93) and reproducibility (ICC = 0.87) with SWV (ICC = 0.84-0.93). The AUC of native T1 values were 0.84, 0.84, and 0.75 for diagnosing significant fibrosis (≥ F2) and liver cirrhosis (F4) and detecting fibrosis progression, and those of SWV were 0.81, 0.86, and 0.7, respectively. No significant difference in performance was found between the two quantitative parameters (p ≥ 0.496). For detecting fibrosis regression, native T1 values had a better accuracy (AUC = 0.99) than SWV (AUC = 0.56; p = 0.002).
CONCLUSION: Native T1 mapping may be a reliable and accurate method for noninvasively assessing liver fibrosis. Compared with ARFI elastography, it provides similar good repeatability and reproducibility, a similar high accuracy for staging fibrosis, and a better accuracy for detecting fibrosis regression.
KEY POINTS: • Native T1 mapping is a valuable tool for noninvasively assessing liver fibrosis and can be measured on virtually all clinical MRI machines without additional hardware or gadolinium chelate injection. • Compared with acoustic radiation force impulse elastography, native T1 mapping yields similar good repeatability and reproducibility and a similar high accuracy for staging fibrosis. • Native T1 mapping provides a significantly better performance for detecting fibrosis regression than acoustic radiation force impulse elastography.
引用
- Li J, Liu H, Zhang C, et al. Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy. Eur Radiol. 2019. PMID: 31338650. doi:10.1007/s00330-019-06335-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。